4
Changes in Ownership
Stoke Therapeutics, Inc. Filed Acc 0001415889-25-008714
Options or other derivatives
- Interim Executive Chair acquired 122,651 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| TZIANABOS ARTHUR Interim Executive Chair | 2025-03-20 | Grant or award · Stock Option (Right to Buy) | +122,651 | 122,651 | D | ||
Loading xslF345X05/form4-03202025_100333.xml…